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A  number of recent studies have demonstrated that mononuclear phagocytes 
use an oxygen-dependent mechanism to kill or inhibit the replication of a diverse 
group  of intracellular  pathogens  (1-10).  In  the  mouse  peritoneal  macrophage 
model,  this  mechanism,  which  generates  superoxide anion  (O~-) and  hydrogen 
peroxide  (H202),  appears  to  be  broadly  effective  since  it  contributes  to  the 
activity of normal and activated macrophages against ingested fungi (6), protozoa 
(1-5,  8,  9,  1 1),  and  mycobacteria  (7).  Although  soluble  lymphocyte products 
(lymphokines) are known to enhance the macrophage's oxidative and antimicro- 
bial  activity  in  parallel  (4,  1 1),  the  ability  of  lymphokine-stimulated  mouse 
macrophages  to  inhibit  the  growth  of  Chlamydia  psittaci  does  not  appear  to 
require respiratory burst activity (12). This report extends the latter observation 
by demonstrating that once activated by lymphokine, oxidatively deficient human 
macrophages  and  mouse  fibroblasts  can  successfully  inhibit  the  intracellular 
replication of both Toxoplasma gondii and C. psittaci. 
Materials and  Methods 
Cells.  Monolayers of resident peritoneal macrophages from normal BALB/c mice (3), 
mouse L cells (fibroblasts) (12), and human monocytes derived from the peripheral blood 
mononuclear cell fraction (10,  13) were prepared and cultivated on glass coverslips in 5% 
CO2-95% air at 37°C (3,  10,  12,  13).  Peritoneal macrophages and L cells were cultured 
for 24 h before infection or assay in Eagle's minimum essential medium (Gibco Labora- 
tories, Grand Island, N.Y.) containing 10-20% heat-inactivated fetal bovine serum (Gibco 
Laboratories), penicillin (100  U/ml), and streptomycin (100 tzg/ml) (3,  12). Monocytes 
from normal donors and three patients with chronic granulomatous disease (CGD) ~ (10) 
were maintained for 9-16 d before use in RPMI  1640 medium (Flow Laboratories, Inc., 
Rockville, MD) with 20% beterologous heat-inactivated human serum and antibiotics, and 
were designated monocyte-derived macrophages (10,  13). 
Lympho~,te Products (Lymphokines) and Cell b~fection.  Cultures of normal BALB/c spleen 
cells (5 x  106/m]) were stimulated for 48 h with 5 #g/ml of concanavalin A (Con A) (3, 
* Supported  by research  grants  A1  16963, 16459, and  06202  from the  U.  S.  Public Health 
Service, and by grant RF 78021 from The Rockefeller Foundation. 
Recipient  of a  Career  Development  Award  in  Geographic  Medicine from The  Rockefeller 
Foundation. 
Present address is the Department of Medical Microbiology, ]'he University of Wisconsin Medical 
School, Madison, WI. 
i After triggering with PMA (100 ng/ml), 1 d-old monocytes from these 3 CGD patients released 
24 + 9 nmol/mg per 90 rain; Id cells front normal donors released 1,015 _+ 58 nmol/mg per 90 min 
(10). 
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11). Human mononuclear cells (3 X 106/ml) were cultivated in 5% CO2-95% air at 37°C 
with  15  ug/ml of Con  A  for 48  h  (10).  Control  (sham)  lymphokines, which did not 
enhance phagocyte oxidative or antimicrobial activity, were obtained from unstimulated 
cell cultures to which Con A was added at the end of the 48 h incubation period (3,  10, 
11). Supernates were centrifuged, sterilized by filtration, and stored at 4°C. 
To induce microbistatic activity, (a) freshly plated peritoneal macrophages were culti- 
vated for 24 h with 20% lymphokine plus 8 mg/ml of heart infusion broth (HIB) (Difco 
Laboratories, Detroit, MI) (11); (b) L cells did not require HIB and were incubated for 
24 h with 20% mouse lymphokine alone; and (c) after 9-16 d in culture, monocytes were 
treated for 3 d with 10% fresh human lymphokine (10,  13). Unstimulated and activated 
cells were then challenged for 1-2 h with 1 x  10 s RH strain T. gondi(trophozoites (1) or 
one 50%  infectious dose (IDs0) of C. psittaci  (12).  Uningested orgamsms were removed 
and standard medium was added.  18 h  later, the extent of intracellular replication was 
assessed by enumerating the number of toxoplasmas per vacuole (1) and the percent of 
cells infected with C. psittaci (12).  Microbial  ingestion by control and activated cells was 
comparable (3,  10-12,  14). 
Oxidative Burst lnhibitors.  Lymphokine-stimulated cells were also treated (a) 3 h before 
and during infection with 2 mg/ml catalase or medium free of glucose (1), (b) 3 h before 
infection with 200 ng/ml phorbol myristate acetate (PMA) (15), or (c) for 24 h before 
infection with tumor cell conditioned medium (TCM) (16) provided by Dr.  C. Nathan 
and Dr. A. Szuro-Sudol (The Rockefeller University, New York). 
Assam's for Oxidative  Activity  and Phagolvsosomal Fusion.  Cellular oxidative activity was 
assessed by the scopoletin method for H202 release (1, 4,  10,  13), qualitative nitroblue 
tetrozolium (NBT) reduction (10,  11), and luminol-enhanced chemiluminescence (17). 
The latter was inhibited >90% by superoxide dismutase (100 ug/ml) plus catalase (200 
t~g/ml). Phagosome-lysosome fusion was assessed by the acridine orange technique (1). 
Results 
Oxidative  a~d  A~timicrobial  Activity  of  Unstimulated  and  Lymphokb,e-treated 
Cells.  Resident  peritoneal  macrophages,  L  cells,  and  normal  human  macro- 
phages displayed comparably low levels of oxidative activity, and supported the 
intracellular  replication  of both  T.  go,dE  and  C.  psittaci  (Table  I  and  Fig.  1). 
These unstimulated cells generated small amounts of H202 after PMA triggering, 
and  showed  relatively  little  or  no  NBT  reduction  or  chemiluminescence  in 
response  to  toxoplasma or chlamydial ingestion.  The addition of lymphokine, 
however,  induced all  three  cell  populations to exert  appreciable  microbistatic 
activity. Consistent with previous observations (10,  1 1,  13),  this acquired anti- 
microbial activity for human and mouse macrophages was paralleled by a clearly 
enhanced capacity to generate oxygen intermediates in response to either PMA 
or microbial  ingestion  (Table  I).  Lymphokine-stimulated L  cells also achieved 
virtually identical toxoplasmastatic and chlamydiastatic effects, but displayed this 
activity in the absence of an augmented oxidative burst response. 
Monocytes from patients  with  CGD,  cells which generate  scant  amounts of 
O~- and H2021 (5, 8,  10), were also cultivated for 9-16 d  and then treated with 
lymphokine before infection. Like oxidatively deficient L  cells, activated CGD 
macrophages  readily inhibited  the  replication  of both  T.  gondii  and C.  psittaci 
(Table I). Not unexpectedly, lymphokine stimulation did not enhance the CGD 
macrophage's minimal level of oxidative activity. 
E/J(ct of'Oxidative Burst l~lhibitors.  To further document that the microbistatic 
effects of in vitro activated, oxidatively deficient cells did not require an intact 
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TABLE  I 
Cellular Oxidative and Antimicrobial Activities 
H~O~  Percent cells NBT-positive!  Chemiluminescence II  Antimicrobia[  activity s 
Release * 
(;ell population and 
treatment*  Toxo-  Toxoplas-  Percent cells 
PMA  PMA  Zymosan  plasma  PMA  CP  mas per  CP-infected 
vacuole 
Resideltt mouse macrophage,~ 
Control  78±12  91+2  82±4  17±4  29.2_+7.8  11.3_+4.2  4.6 ±  0.2  40±5 
+LK+HIB  122± 10  89±4  75±2  59±7  148.0±91.2  33.9± 18.2  1.2±0.2  10±2 
Mtm.~e L ~el/~ 
Control  42 ±  7  0  --**  0  0.134  --  5.8 ± 0.3  46 ± 8 
+LK  35±9  0  --  0  0.167  --  1.84-0.1  5±1 
.\'o~ mtt[ humoll  matrophages 
Control  129-+17  83-+4  82±8  22±4  --  --  4.8--.0.3  43±6 
±  LK  702 4- 68  93 4- 5  87 ± 3  69 ±  6  --  --  1.9 4- 0.4  7 ± 2 
CGD mocroflhage.~ 
Control  36 ±  11  <1  0  0  --  --  4.6 4- 0.4  40 ±  13 
+ LK  49 ±  10  <1  <1  0  --  --  2.0 ± 0.3  6 ± 2 
* Cells were cultivated in medium alone (control)  or treated with lymphokine  (LK) as described  in Materials and Methods. 
~: nmol of HiOt released  per mg of adherent cell protein in 90 min after triggering with PMA (100 ng/ml) (1,  10). Results are tbe 
mean ± SEM of 3-19 experiments for each cell type performed in triplicate. 
! Percent  of cells showing blue-black  formazan  precipitation I h after ingestion of opsonized  zymosan particles  (5 x  106/ml.), viable 
toxoplasmas  (1 X 106/ml),  or stimulation with PMA (I00 ng/ml) (1-3,  10). Mean 4- SEM of three to four experiments. 
tl Maximum  acpm/min x  10  -s during 15 min of exposure to PMA (100 ng/ml) or 50 I Ds0 of C. psittaci (CP) (17).  Background 
Acpm/min ×  10  -~ for unstimulated cells: mouse macrophages  (control} 3.6 4- 0.2, (LK + HIB) 13.0 4- 8.2;  L cells (control)  0.125, 
(+ LK) 0.287.  Results are the mean  :t: SEM of 5-10 experiments for mouse macrophages  and tbe mean of 2 similar experiments 
for L cells, each performed in duplicate. 
v 18 h after infection.  Results are the mean 4- SEM of 5-9 duplicate experiments for each cell type for T. gondii (toxoplasma) and of 
5-14 experiments for C. psittaci (CP). The mean  percent inhibition of C. psittaci replication induced by lymphokine stimulation 
[(percent  control cells infected -  percent treated cells infected)/percent control ceils infected}  X 100 (12) was as follows: mouse 
macrophages,  75%; L cells, 89~; normal human macrophages,  84%; and CGD macrophages,  80%. 
** Not done. 
FIGURE  1.  Phase-contrast  micrographs  showing  mouse  L  cells 18 b  after infection supporting 
the intracellular  replication  ofC.  psittaci (A) and  T. gondii  (B).  In A, each of the large inclusions 
contains numerous  chlamydiae.  In C, L  cells pretreated  with 20% Con A  lymphokine  effectively 
inhibit T.  god,diS  replication  18  h  after  infection,  x  800. MURRAY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Effect of Oxidative Burst Inhibitors on Lymphokine-stimulated Antimicrobial 
Activity* 
237 
Pretreatment 
Toxoplasmas per vacuole*  Percent inhibition of C. psittaci 
replication* 
Mouse macro-  Mouse macro- 
phage  L cell  phage  L cell 
None  1.2 4- 0.1  1.9 4- 0.2  85 4- 4  83 4- 6 
No glucose  3.6 4- 0.4  2.0 4- 0.2  80 ±  5  76 +  3 
PMA  3.4 4- 0.3  2.1 4- 0.3  75 4- 6  74 4- 4 
Catalase  3.2 4- 0.3  1.8 4- 0.2  83 +  4  85 4- 5 
TCM  3.5 4- 0.4  2.2 4- 0.3  80 4- 3  81 4- 3 
* Cells were activated overnight, and before infection were treated with the indicated agents as 
described in Materials and Methods.  Results are the mean 4- SEM of three to five experiments, 
18 h after infection. 
* For unstimulated control cells cultivated in medium alone, the number of toxoplasmas per vacuole 
was  4.7  +-  0.3  (mouse  macrophages) and  5.8  4-  0.4  (L  cells).  Percent  inhibition of C. psittaci 
replication was calculated as indicated in Table  I  legend.  For  control cells, 42  4- 6%  (mouse 
macrophages) and 48 4- 5% (L cells) were infected with C. psittad. 
TABLE  III 
Phagolysosomal Fusion within Microbistatic Cells* 
Percent vacuoles stained at 2 h* 
Lymphokine-treated cells  Viable  Dead 
Zymosan  toxoplasmas  toxoplasmas 
Peritoneal macrophages  48 +- 6  10 +  4  59 4- 7 
L cells  ND  ~  4 4- 2  71  -.+ 5 
CGD macrophages  62 -+ 6  12 4- 5  69 4- 7 
* Cells were activated for 1-3 d (see Materials and Methods), pulsed for 20 min with 
acridine orange, 5/~g/ml, and 30 rain later were challenged for  1 h  with 5  x  l0  s 
opsonized zymosan particles or 1 x  106 viable or heat-killed toxoplasmas (1). After 
2 h of additional incubation, cells were examined using simultaneous phase-contrast 
and  fluorescent  microscopy  for  the  transfer  of acridine orange  to  phagocytic 
vacuoles (1). 
* Percent of vacuoles housing ingested zymosan or toxoplasmas that stained bright 
red-orange.  Unstained intravacuolar particles and parasites fluoresced pale green 
(1).  Results are  the  mean  4-  SEM  of three  to  four  experiments performed  in 
duplicate. 
! Not done. 
known to inhibit the macrophage's capacity to secrete OF and H202 by up to 
90% (I,  15,  16). As previously reported, pretreatment with PMA (15), catalase 
(1), TCM (16), and medium free of glucose (1) all readily reversed the toxoplas- 
mastatic activity of in vitro activated peritoneal macrophages (Table II). These 
same procedures, however, had no appreciable effect on either the inhibition of 
T.  gondii  replication  by  activated  L  cells  or  the  chlamydiastatic  capacity  of 
lymphokine-stimulated L cells or macrophages (12). 
Phagolysosomal Fusion within Microbistatic  Cells.  Since lysosomal agents may be 
important in oxygen-independent antimicrobial activity, and the ability to inhibit 
phagosome-lysosome fusion may aid T. gondii and C. psittaci in parasitizing normal 
cells (12, 18), we also explored whether fusion takes place in oxidatively deficient 
microbistatic cells. As judged by the transfer of acridine orange from prelabeled 
lysosomes (1), fusion readily occurred with vacuoles that housed ingested zymosan 
particles and  heat-killed T.  gondii  (Table  III).  Within the  same activated cell 
populations,  however, <12%  of viable intravacuolar toxoplasmas showed flu- 238  MURRAY  E'F  AL.  BRIEF  DEFINITIVE  REPORT 
orescent  staining,  which  suggested  that  lymphokine-induced toxoplasmastalic 
activity can occur in the absence of lysosomal fusion. 
Discussion 
These  results  suggest  that  in  addition  to  their  well  established  capacity  to 
enhance the oxidative activity of both human and murine macrophages (4,  10, 
11,  13),  soluble  lymphocyte products  can  also  effectively  stimulate  and  thus 
regulate an apparent oxygen-independent intracellular antimicrobial mechanism 
as well. Since the latter's toxoplasmastatic effects do not appear to depend upon 
phagolysosomal fusion,  it  would seem  unlikely that  the  delivery  of lysosomal 
enzymatic constituents directly mediate this microbistatic activity.  Other inves- 
tigators (5, 18) have similarly concluded that lysosomal fusion is not a prerequisite 
for  the  inhibition  of T.  go~Mii  replication.  It  should  be  noted,  however,  that 
acidification of macrophage phagosomes may occur in the absence of fusion (19), 
and it is possible that some small molecular weight cytoplasmic proteins may not 
require lysosomal fusion for vacuolar entry. Thus, the effects of either or both 
of these two potential antimicrobial  mechanisms nfight explain  the activity we 
have  observed.  In  addition,  since  the  assays  we  used  to  designate  cells  as 
oxidatively deficient detect only the 02 and H202 secreted extracellularly, it is 
also still possible that lymphokine may have enhanced the intracellular production 
of 02 or H,,O2, which then could have played some role. 
Other studies with human monocytes have also provided data supporting the 
presence of this apparent oxygen-independent mechanism and its activity against 
intracellular  pathogens.  Although  less  active  than  normal  cells,  fresh  CGD 
monocytes have been  reported to kill 45-50%  of ingested toxoplasmas (5,  8), 
and effectively inhibit C. psittaci replication (14).  In addition, despite displaying 
little activity against the promastigote form of Leishmania  donovani  during the 
first 24  postphagocytic hours (whereas normal cells kill 80-90%),  CGD  mono- 
cytes can  kill 40%  of ingested promastigotes by 48  h, and this activity can  be 
strikingly enhanced by lymphokine (10).  However,  lymphokine-activated CGD 
monocytes  inhibit  but  do  not  kill  the  amastigote  form  of L  do~wvani  (10), 
suggesting that intracellular pathogens display differential sensitivity to not only 
oxygen-dependent mechanisms (1-4), but to oxygen-independent agents as well. 
These studies indicate, therefore, that in addition to the effects of toxic oxygen 
intermediates,  the presence, activity, and susceptibility to oxygen-independent 
mechanisms  should  also  be  considered  when  examining  those  factors  which 
determine the fate of intracellular pathogens. 
Summary 
To  determine  if  mechanisms  other  than  the  generation  of  toxic  oxygen 
intermediates  are  active  against  intracellular  pathogens,  oxidatively  deficient 
mouse L  cells and monocyte-derived macrophages from patients with chronic 
granulomatous disease were stimulated with soluble lymphocyte products.  De- 
spite no enhancement in oxidative activity, these cells displayed effective microb- 
istatic  activity  against  both  7".  go~dii  and  C.  psittaci.  These  results  suggest  a 
potential  role  for  nonoxidative  mechanisms in  the  mononuclear  phagocyte's 
activity against intracellular pathogens, and indicate that lymphokines can regu- 
late both oxygen-dependent and oxygen-independent antimicrobial responses. MURRAY ET  AL.  BRIEF  DEFINITIVE  REPORT  239 
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